Stockscreener 앱 받기
1.14
0.00%
0.00
시간 외 거래:
1.12
-0.02
-1.75%
전일 마감가:
$1.14
열려 있는:
$1.28
하루 거래량:
960.09K
Relative Volume:
1.24
시가총액:
$93.69M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-1.443
EPS:
-0.79
순현금흐름:
$-47.97M
1주 성능:
-8.06%
1개월 성능:
+33.79%
6개월 성능:
+248.73%
1년 성능:
-27.85%
1일 변동 폭
$1.08
$1.30
1주일 범위
$0.97
$1.4286
52주 변동 폭
$0.1253
$1.63
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
1.14 | 93.69M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
345.55 | 84.29B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.90 | 14.41B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
152.97 | 13.37B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
134.50 | 13.18B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
187.90 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
Oncology Institute Inc 주식(TOI)의 최신 뉴스
TOI Launches Florida Oncology Network, a Fully Delegated - GlobeNewswire
The Oncology Institute announces launch of the Florida Oncology Network - TipRanks
Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts - Stock Titan
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute CEO acquires $23,584 in stock By Investing.com - Investing.com Australia
Oncology institute’s chief medical officer buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
Oncology institute director Brad Hively acquires $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase - Investing.com India
Oncology Institute Executives Make Significant Stock Purchases - TradingView
Oncology institute director Karen Johnson acquires $37,734 in shares - Investing.com
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com India
Oncology institute director Richard Barasch acquires $1.42 million in shares By Investing.com - Investing.com South Africa
Oncology institute director Richard Barasch acquires $1.42 million in shares - Investing.com India
Oncology institute CFO Robert Ross buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges - MSN
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript - Insider Monkey
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million - Yahoo Finance
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
The Oncology Institute Reports Strong Q4 Revenue Growth - TipRanks
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth - Investing.com Australia
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth By Investing.com - Investing.com South Africa
The Oncology Institute Announces $16.5 million Private Placement - GlobeNewswire
The Oncology Institute Secures $16.5 Million In Private Placement - Nasdaq
Oncology Institute, Inc. Prepares for PIPE Financing - TipRanks
The Oncology Institute, Inc. Announces $16.5 Million Private Placement Agreement - Nasdaq
Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - StockTitan
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - GlobeNewswire
Oncology Institute Lands Major $16.5M Backing as Insiders Double Down - Stock Titan
Wilmot Cancer Institute earns prestigious National Cancer Institute designation - THE WELLSVILLE SUN
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% – Time to Sell? - Armenian Reporter
A groundbreaking project at the Oncology Institute in Shaare Zedek Medical Center - The Jerusalem Post
Cancer Care - Cone Health
In the Green: Oncology Institute Inc (TOI) Closes at 0.82, Up/Down -7.68 from Previous Day - The Dwinnex
Oncology Institute Inc [TOI] Investment Appeal on the Rise - Knox Daily
Singapore Cancer Center opens in Cebu - SunStar Philippines
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.63%
자본화:
|
볼륨(24시간):